AAAAAA
Results:
1-16
|
Results: 16
Authors:
JOSIC D
SCHULZ P
BIESERT L
HOFFER L
SCHWINN H
KORDISKRAPEZ M
STRANCAR A
Citation: D. Josic et al., ISSUES IN THE DEVELOPMENT OF MEDICAL PRODUCTS BASED ON HUMAN PLASMA, Journal of chromatography B. Biomedical sciences and applications, 694(2), 1997, pp. 253-269
Authors:
BIESERT L
GARTNER T
HOFFER L
JOSIC D
SUHARTONO H
MENTZ S
BREDE HD
SCHWINN H
Citation: L. Biesert et al., VIRAL SAFETY OF A NEW FACTOR-IX (OCTANINE F(R)) - COMBINATION OF SOLVENT DETERGENT (SD) TREATMENT WITH AN ULTRAFILTRATION STEP/, Thrombosis and haemostasis, 1997, pp. 2071-2071
Authors:
BIESERT L
SUHARTONO H
BREDE HD
SCHWINN H
Citation: L. Biesert et al., VIRAL SAFETY OF OCTAPLAS(R) - VALIDATION WITH RESPECT TO THE LIMITATIONS OF THE SOLVENT DETERGENT STEP/, Thrombosis and haemostasis, 1997, pp. 2080-2080
Authors:
GARTNER T
BIESERT L
MENTZ S
SUHARTONO H
BREDE HD
SCHWINN H
Citation: T. Gartner et al., REMOVAL OF NONENVELOPED VIRUSES BY ANION-EXCHANGE CHROMATOGRAPHY IN THE MANUFACTURING PROCESS OF A SOLVENT DETERGENT-TREATED FACTOR VIII-CONCENTRATE, Thrombosis and haemostasis, 1997, pp. 2090-2090
Authors:
BIESERT L
Citation: L. Biesert, VIRUS VALIDATION STUDIES OF IMMUNOGLOBULIN PREPARATIONS, Clinical and experimental rheumatology, 14, 1996, pp. 47-52
Authors:
BIESERT L
LEMON S
GOUDEAU A
SUHARTONO H
WANG LR
BREDE HD
Citation: L. Biesert et al., VIRAL SAFETY OF A NEW HIGHLY PURIFIED FACTOR-VIII (OCTATE), Journal of medical virology, 48(4), 1996, pp. 360-366
Authors:
HOFFER L
SCHWINN H
BIESERT L
JOSIC D
Citation: L. Hoffer et al., IMPROVED VIRUS SAFETY AND PURITY OF A CHROMATOGRAPHICALLY PRODUCED FACTOR-IX CONCENTRATE BY NANOFILTRATION, Journal of chromatography B. Biomedical applications, 669(2), 1995, pp. 187-196
Authors:
BIESERT L
GARTNER T
LEMON S
HOROWITZ B
SUHARTONO H
WANG L
BREDE HD
Citation: L. Biesert et al., OCTAPLAS - A VIRUS-INACTIVATED ALTERNATIV E TO FROZEN FRESH PLASMA, Infusionstherapie und Transfusionsmedizin, 22, 1995, pp. 2-4
Authors:
BIESERT L
LEMON S
SUHARTONO H
WANG L
RUBSAMEN H
Citation: L. Biesert et al., VIRUS VALIDATION EXPERIMENTS ON THE PRODUCTION PROCESS OF OCTAVI SDPLUS, Blood coagulation & fibrinolysis, 6, 1995, pp. 48-54
Authors:
BIESERT L
GARTNER T
SUHARTONO H
WANG LR
BREDE HD
Citation: L. Biesert et al., COMBINATION OF SD TREATMENT AND MODIFIED PASTEURIZATION - DOUBLE VIRUS INACTIVATION OF A HIGHLY PURIFIED FACTOR-VIII-CONCENTRATE (OCTAVI-SDPLUS), Thrombosis and haemostasis, 73(6), 1995, pp. 1016-1016
Authors:
GARTNER T
SUHARTONO H
WANG LR
BREDE HD
BIESERT L
Citation: T. Gartner et al., VIRAL SAFETY OF A NEW FACTOR-IX PREPARATION (OCTANINE-F), Thrombosis and haemostasis, 73(6), 1995, pp. 1021-1021
Authors:
BIESERT L
GOUDEAU A
SUHARTONO H
WANG LR
BREDE HD
Citation: L. Biesert et al., VIRAL SAFETY OF A NEW POLYVALENT INTRAVENOUS IMMUNOGLOBULIN (OCTAGAM), Thrombosis and haemostasis, 73(6), 1995, pp. 1069-1069
Authors:
GEHRINGER W
GARTNER T
SUHARTONO H
WANG L
BREDE HD
BIESERT L
Citation: W. Gehringer et al., VIRAL SAFETY OF A NEW FIBRIN GLUE (OCTACOL), Thrombosis and haemostasis, 73(6), 1995, pp. 1470-1470
Authors:
SCHWINN H
STADLER M
GEHRINGER W
JOSIC D
BIESERT L
NUR I
Citation: H. Schwinn et al., COMPARISON OF BIOCHEMICAL AND MECHANICAL-PROPERTIES OF HUMAN PLASMA-DERIVED FIBRIN GLUES, Thrombosis and haemostasis, 73(6), 1995, pp. 1473-1473
Authors:
RUBSAMENWAIGMANN H
PFUTZNER A
BIESERT L
Citation: H. Rubsamenwaigmann et al., ANTIVIRAL DRUGS, Immunitat und Infektion, 21(4), 1993, pp. 106-110
Authors:
METZGER JW
SAWYER WH
WILLE B
BIESERT L
BESSLER WG
JUNG G
Citation: Jw. Metzger et al., INTERACTION OF IMMUNOLOGICALLY-ACTIVE LIPOPEPTIDES WITH MEMBRANES, Biochimica et biophysica acta, 1149(1), 1993, pp. 29-39
Risultati:
1-16
|